8-KEarnings & ResultsExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Oct 22, 2025)

Filed October 22, 2025For Securities:BSX

Summary

Boston Scientific Corporation (BSX) has filed a Form 8-K report dated October 21, 2025, to announce its financial results for the third quarter ended September 30, 2025. The report primarily directs investors to a press release, furnished as Exhibit 99.1, which contains the detailed financial outcomes and operational performance for the quarter. Investors should refer to this press release for comprehensive information regarding revenue, profitability, segment performance, and any forward-looking guidance provided by the company. This filing serves as a notification mechanism for the release of the company's quarterly financial performance. It is important to note that the information within this Item 2.02 and its accompanying exhibit is furnished and not deemed 'filed' for the purposes of Section 18 of the Exchange Act. Therefore, while the information is publicly available, it does not carry the same legal implications as information that is formally filed. Investors should consult the press release for substantive details on BSX's Q3 2025 results.

Key Highlights

  • 1Boston Scientific Corporation (BSX) filed an 8-K on October 21, 2025.
  • 2The filing announces financial results for the third quarter ended September 30, 2025.
  • 3Detailed financial information is provided in a press release furnished as Exhibit 99.1.
  • 4Investors are directed to the press release for Q3 2025 earnings and financial condition updates.
  • 5The press release contains information previously announced by the company on October 22, 2025.
  • 6Information in Item 2.02 and Exhibit 99.1 is furnished, not filed, under Section 18 of the Exchange Act.
  • 7Exhibit 104 provides the Cover Page Interactive Data File in XBRL format.

Frequently Asked Questions

The detailed financial results for the third quarter ended September 30, 2025, are available in the press release furnished by Boston Scientific Corporation as Exhibit 99.1 to this 8-K filing. Investors should refer to this press release for comprehensive information.

The event date of October 21, 2025, likely refers to the date Boston Scientific Corporation completed the action described in the filing (e.g., issuing the press release). The filing date of October 21, 2025, is when the report was officially submitted to the SEC. The press release itself was issued on October 22, 2025, according to the report.

The information contained in Item 2.02 of this 8-K and its accompanying Exhibit 99.1 is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not subject the company to the liabilities of that section. However, it is still publicly available information for investors.

Exhibit 99.1 is the press release issued by Boston Scientific Corporation on October 22, 2025, which contains their financial results for the third quarter of 2025. This exhibit is the primary source of detailed financial and operational information for the reported period.